Parkside Financial Bank & Trust Blueprint Medicines Corp Transaction History
Parkside Financial Bank & Trust
- $742 Million
- Q4 2024
A detailed history of Parkside Financial Bank & Trust transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Parkside Financial Bank & Trust holds 84 shares of BPMC stock, worth $9,271. This represents 0.0% of its overall portfolio holdings.
Number of Shares
84Holding current value
$9,271% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BPMC
# of Institutions
355Shares Held
60.7MCall Options Held
2.25MPut Options Held
1.18M-
Vanguard Group Inc Valley Forge, PA6.68MShares$738 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$734 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$595 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA3.96MShares$438 Million0.07% of portfolio
-
State Street Corp Boston, MA2.77MShares$305 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.59B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...